Evidence map›Paper›PMID 42483116›Full record

ArticleCureus2026

Disruption of the Anterior Borders of the Mammary Gland on Ultrasound Does Not Always Indicate the Presence of Invasive Breast Cancer Components: A Case Report.

Aoi Suenaga, Shoji Oura

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aoi SuenagaDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.
Shoji OuraDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disruption of the anterior borders of the mammary gland on ultrasound usually indicates the presence of invasive breast cancer components in the tumor. A 60-year-old woman was referred to our hospital for a detailed examination of an abnormality on screening mammography. Mammography showed distortion of the mammary gland and no definite masses in the left breast. Ultrasound also did not depict any masses but showed low echoes with indistinct margins and disruption of the anterior borders of the mammary gland. MRI of the target lesion showed low signals on T1-weighted images and very weak high signals on fat-suppressed T2-weighted images, with initial slow enhancement followed by a plateau pattern on dynamic studies. These imaging findings led us to perform a vacuum-assisted biopsy of the target areas, which pathologically showed non-invasive cancer cells growing in a cribriform fashion. Despite the lack of invasive components in the biopsy specimen, the patient underwent breast-conserving surgery and sentinel node biopsy to avoid undertreatment. Frozen section confirmed no lymph node metastasis and negative surgical margins. Postoperative pathological examination showed that the breast cancer had sparse ductal carcinoma in situ growing in cribriform and solid patterns, along with focal depression of the background fibrous stroma edges at the presumed disruption areas of the mammary gland anterior borders. The patient recovered uneventfully, has received adjuvant radiotherapy to the conserved breast, and has been well on endocrine therapy for four months. Diagnostic physicians should note that disruption of the anterior borders of the mammary gland on ultrasound does not always indicate the presence of invasive breast cancer components.

Indexed as

back ground fibrous stromabreast cancerdisruption of anterior bordersmammary glandnon-invasive cancer

Identifiers

PMID42483116
PMCPMC13387815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.